A review of commercially available thrombin generation assays

Research and Practice in Thrombosis and Haemostasis

Volumn 2, Issue 1, 2018, Pages 42-48

  Kintigh, Jeremy ^a,b   Monagle, Paul ^a,b,c   Ignjatovic, Vera ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

substrate; thrombin; thrombin generation; thrombogram

Indexed keywords

THROMBIN;

BLOOD CLOTTING; CHROMOGENIC ASSAY; DATA PROCESSING; ENZYME SUBSTRATE; FLUOROGENIC ASSAY; HUMAN; INFORMATION PROCESSING; PRIORITY JOURNAL; REVIEW; SUBSTRATE CONCENTRATION; THROMBIN GENERATION ASSAY; THROMBIN TIME;

EID: 85061409697     PISSN: None     EISSN: 24750379     Source Type: Journal    
DOI: 10.1002/rth2.12048     Document Type: Review

References (33)

1. Hemker HC, Wielders S, Kessels H, Béguin S. Continuous registration of thrombin generation in plasma, it's use for the determination of the thrombin potential. Thromb Haemost. 1993;70:617–24.
2. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurements in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4–15.
3. Macfarlane RG, Biggs R. A thrombin generation test; the application in haemophilia and thrombocytopenia. J Clin Pathol. 1953;6:3–8.
4. Loeffen R, Kleinegris MC, Loubele ST, et al. Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method. J Thromb Haemost. 2012;10:2544–54.
5. Parry MA, Stone SR, Hofsteenge J, Jackman MP. Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem J. 1993;290:665–70.
6. Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost. 2005;3:1861–72.
7. Dargaud Y, Luddington R, Gray E, et al. Standardisation of thrombin generation test–which reference plasam for TGT? An international multicentre study Thromb Res. 2010;125:353–6.
8. Devreese K, Wijns W, Combes I, Van kerckhoven S, Hoylaerts MF. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombin analysis. Thromb Haemost 2007;98:600–13.
9. Lawrie AS, Gray E, Leeming D, et al. A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique. ‎Br J Haematol. 2003;123:335–41.
10. Duckers C, Simioni P, Spiezia L, et al. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mind bleeding symptoms. Blood. 2010;115:879–86.
11. Innovin ETP Datasheet Insert. Marburg, Germany: Siemens; 2010.
12. Technothrombin TGA Datasheet Insert. Vienna, Austria: Technoclone GmbH; 2007.
13. Chandler WL, Roshal M. Optimization of plasma fluorogenic thrombin-generation assay. Am J Cin Pathol. 2009;123:169–79.
14. Hemker HC, Kreemers R. Data management in thrombin generation. Thromb Res. 2013;131:3–11.
15. van Veen JJ, Gatt A, Makris M. Thrombin generation testing in routine clinical practice: are we there yet? Br J Haematol. 2008;142:889–903.
16. De Smedt E, Al Dieri R, Spronk HM, Hamulyak K, ten Cate H, Hemker HC. The technique of measuring thrombin generation with fluorogenic substrates: 1. Necessity of adequate calibration. Thomb Hamost. 2008;100:343–9.
17. Butenas S, Orfeo T, Lawson JH, Mann KG. Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes. Biochem. 1992;31:5399–411.
18. Sato E, Matsuhisa A, Sakashita M, Kanaoka Y. New water-soluble fluorogenic amine.: 7-Aminocoumarin-4-methanesulfonic acid (ACMS) and related substrates for proteinases. Chem Pharm Bull. 1988;36:3496–502.
19. Dinkelaar J, Molenaar PJ, Ninivaggi M, de Laat B, Brinkman HJ, Leyte A. In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban. J Thromb Haemost. 2013;11:1111–8.
20. Duchemin J, Pan-Petesch B, Arnaud B, Blouch MT, Abgrall JF. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. J Thromb Haemost. 2008;99:767–73.
21. Baglin T. The measurement and application of thrombin generation. Br J Haematol. 2005;130:653–61.
22. Campo G, Pavasini R, Pollina A, et al. Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? Blood Coagul Fibrinolysis. 2012;23:680–7.
23. Tunstall AM, Merriman JM, Milne I, James K. Normal and pathological serum levels of α-2-macroglobulins in men and mice. J Clin Pathol. 1975;28:133–9.
24. Ignjatovic V, Greenway A, Summerhayes R, Monagle P. Thrombin generation: the functional role of alpha-2-macroglobulin and influence of developmental haemostasis. Br J Haematol. 2007;138:366–8.
25. Ho AH, Cheng CC, Lee SC, et al. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha-2-macroglobulin, vitamin D binding protein and apolipoprotein AI. J Biomed Sci. 2010;17:58–64.
26. Banks RE, Evans SW, Alexander D, Van Leuven F, Whicher JT, McMahon MJ. Alpha-2-macroglobulin state in acute pancreatitis. Raised values of alpha-2-macroglobulin-protease complexes in severe and mild attacks. Gut 1991;32:430–4.
27. Losito R, Gattiker H, Bilodeau G, Verville N, Longpré B. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease. J Lab Clin Med. 1981;97:241–50.
28. Fauci AS, Braunwald E, Kasper DL, et al. Harrisons's Principles of Internal Medicine. 17th ed. New York: McGraw-Hill; 2008.
29. Howie SR. Blood sample volumes in child health research: review of safe limits. Bull World Health Organ. 2011;89:46–53.
30. Ten Cate H. Thrombin generation in clinical conditions. Thromb Res. 2012;129:367–70.
31. Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem. 2016;62:699–707.
32. Perrin J, Depasse F, Lecompte T. Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma. Thromb Res. 2015;136:125–30.
33. Bagot CE, Leishman E. Establishing a reference range for thrombin generation using a standard plasma significantly improves assay precision. Thromb Res. 2015;136:139–43.